ERBB2 and breast cancer: To test the sensitivity of HER2 detection, real time quantitative RT-PCR was performed on BerEP4 immunomagnetic selected leukopak blood spiked with serial dilutions of breast cancer cell lines with varying levels of HER2 amplification [9,10].